Skip to main content
Premium Trial:

Request an Annual Quote

Nycomed to Use Genedata's Screener Software for HTS in Rx Programs

NEW YORK (GenomeWeb News) - Genedata said today it has extended a contract with Nycomed for its Genedata Screener software in pharmaceutical development projects.
 
Screener will enable Nycomed’s researchers to “rapidly capture, visualize, analyze, and manage large volumes of assay data,” Genedata said in a statement.
 
Nycomed’s head of high-throughput screening, Werner Stürmer, said Screener will increase efficiency and quality of screening campaigns and will have a positive impact on the company’s global information network.
 
The software will help Nycomed’s teams at all of its sites “capture, visualize, analyze, and manage large volumes of assay data,” coming from ultra-high throughput screens, single point assays, and high content screens.
 
In November, the companies announced that Genedata would develop and implement scientific databases and other applications for Nycomed’s research-data management and scientific analysis.
 

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.